Log in to save to my catalogue

A Survey of Diagnostic Practices and the Use of Epoprostenol In Patients With Primary Pulmonary Hype...

A Survey of Diagnostic Practices and the Use of Epoprostenol In Patients With Primary Pulmonary Hype...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_200458476

A Survey of Diagnostic Practices and the Use of Epoprostenol In Patients With Primary Pulmonary Hypertension

About this item

Full title

A Survey of Diagnostic Practices and the Use of Epoprostenol In Patients With Primary Pulmonary Hypertension

Publisher

Northbrook, IL: Elsevier Inc

Journal title

Chest, 1998-11, Vol.114 (5), p.1269-1275

Language

English

Formats

Publication information

Publisher

Northbrook, IL: Elsevier Inc

More information

Scope and Contents

Contents

To obtain information about the diagnosis and management of primary pulmonary hypertension (PPH), especially about the use of epoprostenol (Glaxo-Wellcome; Research Triangle Park, NC) in this patient population.
Long-term IV epoprostenol therapy was approved recently for use in patients with PPH who are unresponsive to conventional therapy. Alth...

Alternative Titles

Full title

A Survey of Diagnostic Practices and the Use of Epoprostenol In Patients With Primary Pulmonary Hypertension

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_200458476

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_200458476

Other Identifiers

ISSN

0012-3692

E-ISSN

1931-3543

DOI

10.1378/chest.114.5.1269

How to access this item